Evidence map›Paper›PMID 33574481›Full record

ArticleOncogene2021

Correction to: Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer.

Ok-Seon Kwon, Haeseung Lee, Hyeon-Joon Kong, Eun-Ji Kwon, Ji Eun Park, Wooin Lee, Seungmin Kang, Mirang Kim, Wankyu Kim, Hyuk-Jin Cha

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Oncogene, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Ok-Seon Kwon *College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
Haeseung Lee *Department of Life Sciences, College of Natural Science, Ewha Womans University, Seoul, 03760, Republic of Korea.ORCID http://orcid.org/0000-0002-9947-4032
Hyeon-Joon KongDepartment of Life Sciences, College of Natural Sciences, Sogang University, Seoul, 04107, Republic of Korea.
Eun-Ji KwonCollege of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
Ji Eun ParkCollege of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.
Wooin LeeCollege of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.ORCID http://orcid.org/0000-0001-7805-869X
Seungmin KangKaiPharm, Ewha Womans University, Seoul, 03760, Republic of Korea.
Mirang KimPersonalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea.ORCID http://orcid.org/0000-0001-7415-0077
Wankyu KimDepartment of Life Sciences, College of Natural Science, Ewha Womans University, Seoul, 03760, Republic of Korea. wkim@ewha.ac.kr.
Hyuk-Jin ChaCollege of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea. hjcha93@snu.ac.kr.ORCID http://orcid.org/0000-0001-9277-2662
Seoul National University · KREwha Womans University · KRKorea Research Institute of Bioscience and Biotechnology · KRSogang University · KR

Funding

Immunoproteasome inhibitors for the treatment of Alzheimers diseaseR01AG073122 · NIA · UNIVERSITY OF KENTUCKY · PI KIM, KYUNG BO · 2021 to 2025
$3.1M
NIA NIH HHS R01 AG073122
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33574481
OpenAlexW3129053708

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.